Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1

Laura Smeaton, Victor DeGruttola, Gregory K. Robbins, Robert Shafer. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clinical Trials. 2001. 22: 142-59.

Year

2001

Journal

Controlled Clinical Trials

Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients

Hernan Valdez, Julia A. Metcalf, Barbara Gripshover, Jeffrey M. Jacobson, Ronald T. Mitsuyasu, Michael M. Lederman. Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients. AIDS. 2001. 15: 661-2.

Year

2001

Journal

AIDS

Glucose disorders associated with HIV and its drug therapy

Helene Hardy, Lori Esch, Gene D. Morse. Glucose disorders associated with HIV and its drug therapy. Annals of Pharmacotherapy. 2001. 35: 343-51.

Year

2001

Journal

Annals of Pharmacotherapy

Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus

Catherine Leport, J. Franck, Genevieve Chene, F. Derouin, JL Ecobichon, Sophie Pueyo, Jose Miro, Benjamin J. Luft, Philippe Morlat, H. Dumon. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus. Clinical and Diagnostic Laboratory Immunology. 2001. 8: 579-84.

Year

2001

Journal

Clinical and Diagnostic Laboratory Immunology

Plasma carnitine in HIV-associated neuropathy

David M. Simpson, David Katzenstein, Bettina Haidich, David Millington, Constantin Yiannoutsos, Giovanni Schifitto, Justin C. McArthur. Plasma carnitine in HIV-associated neuropathy. AIDS. 2001. 15: 2207-8.

Year

2001

Journal

AIDS

Population pharmacokinetics of dapson in children with human immunodeficiency virus infection.

Mark Mirochnick, Ellen Rae Cooper, Edmund Capparelli, Kenneth McIntosh, Jane C. Lindsey, Jing Xu, David P. Jacobus, Lynne M. Mofenson, Vincent R. Bonagura, Sharon Appelbaum Nachman, Ram Yogev, Stephen A. Spector. Population pharmacokinetics of dapson in children with human immunodeficiency virus infection.. Clinical Pharmacology & Therapeutics. 2001. 1: 24-32.

Year

2001

Journal

Clinical Pharmacology & Therapeutics

Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection

Elizabeth Livingston, Arlene D. Bardeguez, Jorge Gandia, Mary Jo O'Sullivan, Sharon Huang, Ross E. McKinney, W. N.P. Herbert, Pamela A. Clax, Yi Wang, Sheran Patel, Ruth E. Dickover, Jashvant D. Unadkat. Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection. American Journal of Obstetrics and Gynecology. 2001.

Year

2001

Journal

American Journal of Obstetrics and Gynecology

Duration of ruptured mambranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies.

Paul Palumbo, William T. Shearer. Duration of ruptured mambranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies.. AIDS. 2001. 15: 357-368.

Year

2001

Journal

AIDS

Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

Jean Marie Arduino, Margaret A. Fischl, Kenneth Stanley, Ann C. Collier, Donna Spiegelman. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?. AIDS Research and Human Retroviruses. 2001. 17: 1099-105.

Year

2001

Journal

AIDS Research and Human Retroviruses